| HGNC Family | Sialic acid binding Ig-like lectins (SIGLECs), Immunoglobulin superfamily domain containing, CD molecules (CD) |
| Name | sialic acid binding Ig-like lectin 5 |
| Description | This gene encodes a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family. These cell surface lectins are characterized by structural motifs in the immunoglobulin (Ig)-like domains and sialic acid recognition sites in the first Ig V set domain. The encoded protein is a member of the CD33-related subset of Siglecs and inhibits the activation of several cell types including monocytes, macrophages and neutrophils. Binding of group B Streptococcus (GBS) to the encoded protein plays a role in GBS immune evasion. [provided by RefSeq, Feb 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSIGLEC5 is a sialic acid–binding immunoglobulin‐like receptor predominantly expressed on myeloid cells that acts as an inhibitory checkpoint in innate and adaptive immunity. Engagement of SIGLEC5 by its ligands triggers immunoreceptor tyrosine‐based inhibitory motifs in its cytoplasmic tail, recruiting phosphatases such as SHP‐1 and SHP‐2 to attenuate cellular activation. Several studies have documented that pathogens such as Group B Streptococcus exploit SIGLEC5 through noncanonical protein–protein interactions (via the bacterial β‐protein) to suppress phagocyte responses, an effect balanced in part by the presence of the activating paired receptor SIGLEC14. Moreover, binding of endogenous molecules (e.g., extracellular Hsp70) to SIGLEC5 delivers anti‐inflammatory signals, and increased SIGLEC5 expression on T cells can modulate lymphocyte activation and survival."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructural and biochemical investigations have elucidated the specificity of SIGLEC5 for sialylated glycans. Crystallographic studies reveal a conserved sialic acid binding pocket, involving critical residues (e.g., an essential arginine), while biochemical assays further outline its promiscuous binding to various glycan structures. In addition, SIGLEC5 participates in the uptake of immunoglobulin A (SIgA) via M cell–mediated transcytosis, and its interactions with glycoproteins like PSGL1 regulate leukocyte adhesion and rolling. Notably, SIGLEC5-mediated responses to acute-phase proteins (for example, alpha1-acid glycoprotein) depend on its sialic acid recognition, and recent work has also implicated SIGLEC5 in the endocytic clearance of glycosylated plasma proteins such as ADAMTS13."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in modulating immune cell activation and pathogen evasion, altered expression or genetic variation in SIGLEC5 has important clinical implications. Elevated expression on malignant cells—as seen in certain leukemias—and on activated T cells has spurred interest in its potential as a therapeutic target and biomarker in cancer. In autoimmune and inflammatory conditions, including primary Sjögren’s syndrome, periodontitis, and sepsis, aberrant SIGLEC5 levels correlate with disease severity. Plasma levels of SIGLEC5 have furthermore been associated with critical complications in type 2 diabetes mellitus and may contribute to gene × gene interaction effects underlying susceptibility to chronic inflammatory diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Syed Raza Ali, Jerry J Fong, Aaron F Carlin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20131853"}], "href": "https://doi.org/10.1084/jem.20131853"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24799499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24799499"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Takashi Angata, Toshiyuki Hayakawa, Masahiro Yamanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.06-5800com"}], "href": "https://doi.org/10.1096/fj.06-5800com"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17012248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17012248"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Aaron F Carlin, Yung-Chi Chang, Thomas Areschoug, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20090691"}], "href": "https://doi.org/10.1084/jem.20090691"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19596804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19596804"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Tony Avril, Sylvie D Freeman, Helen Attrill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M502041200"}], "href": "https://doi.org/10.1074/jbc.M502041200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15769739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15769739"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jerry J Fong, Karthik Sreedhara, Liwen Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embj.201591407"}], "href": "https://doi.org/10.15252/embj.201591407"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26459514"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26459514"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Aleksandra Vuchkovska, David G Glanville, Gina M Scurti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Siglec-5 is an inhibitory immune checkpoint molecule for human T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunology (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/imm.13470"}], "href": "https://doi.org/10.1111/imm.13470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35290663"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35290663"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Therése Nordström, Elin Movert, Anders I Olin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.251728"}], "href": "https://doi.org/10.1074/jbc.M111.251728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21795693"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21795693"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Paula C Soto, Maile Y Karris, Celsa A Spina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-012-0951-7"}], "href": "https://doi.org/10.1007/s00109-012-0951-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22945238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22945238"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Nicolas Rochereau, Daniel Drocourt, Eric Perouzel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.1001658"}], "href": "https://doi.org/10.1371/journal.pbio.1001658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24068891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24068891"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Marina A Zhuravleva, Kathryn Trandem, Peter D Sun "}, {"type": "b", "children": [{"type": "t", "text": "Structural implications of Siglec-5-mediated sialoglycan recognition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2007.10.009"}], "href": "https://doi.org/10.1016/j.jmb.2007.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18022638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18022638"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Peter Gunnarsson, Louise Levander, Peter Påhlsson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The acute-phase protein alpha 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.07-8534com"}], "href": "https://doi.org/10.1096/fj.07-8534com"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17675532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17675532"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Marion Pepin, Soraya Mezouar, Julie Pegon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep37953"}], "href": "https://doi.org/10.1038/srep37953"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27892504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27892504"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "E M Rapoport, G V Pazynina, M A Sablina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (Mosc) (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1134/s0006297906050051"}], "href": "https://doi.org/10.1134/s0006297906050051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16732727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16732727"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Adam W Barb, Xu Wang, James H Prestegard "}, {"type": "b", "children": [{"type": "t", "text": "Refolded recombinant Siglec5 for NMR investigation of complex carbohydrate binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Expr Purif (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pep.2013.01.005"}], "href": "https://doi.org/10.1016/j.pep.2013.01.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23321067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23321067"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Masashi Akiyama, Yuka Eura, Koichi Kokame "}, {"type": "b", "children": [{"type": "t", "text": "Siglec-5 and Siglec-14 mediate the endocytosis of ADAMTS13."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.thromres.2022.09.005"}], "href": "https://doi.org/10.1016/j.thromres.2022.09.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36116391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36116391"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Bjoern Biedermann, Diana Gil, David T Bowen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2006.05.026"}], "href": "https://doi.org/10.1016/j.leukres.2006.05.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16828866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16828866"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Paula C Soto, Lance L Stein, Nancy Hurtado-Ziola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0903420"}], "href": "https://doi.org/10.4049/jimmunol.0903420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20231688"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20231688"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Connie L Erickson-Miller, Sylvie D Freeman, Christopher B Hopson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of Siglec-5 (CD170) expression and functional activity of anti-Siglec-5 antibodies on human phagocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Hematol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0301-472x(03)00046-8"}], "href": "https://doi.org/10.1016/s0301-472x(03"}, {"type": "t", "text": "00046-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12763136"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12763136"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jennifer Lee, Jaeseon Lee, SeungYe Baek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Autoimmun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jaut.2019.03.008"}], "href": "https://doi.org/10.1016/j.jaut.2019.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30922727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30922727"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Ju-Yi Li, Xiao-Yan Yang, Xiu-Fang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-11820-x"}], "href": "https://doi.org/10.1038/s41598-017-11820-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28900239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28900239"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Hua Tong, Zhuliang Wei, Jing Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic susceptibility of common polymorphisms in NIN and SIGLEC5 to chronic periodontitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-38632-5"}], "href": "https://doi.org/10.1038/s41598-019-38632-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30765789"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30765789"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "R Mueller, A Chopra, H Dommisch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Periodontitis Risk Variants at "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SIGLEC5"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Impair ERG and MAFB Binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dent Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/00220345211049984"}], "href": "https://doi.org/10.1177/00220345211049984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34852650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34852650"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Roberto Lozano-Rodríguez, José Avendaño-Ortíz, Karla Montalbán-Hernández, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic impact of SIGLEC5-induced impairment of CD8"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " T cell activation in sepsis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2023.104841"}], "href": "https://doi.org/10.1016/j.ebiom.2023.104841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37890368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37890368"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Ricarda Müller, Sandra Freitag-Wolf, January Weiner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Case-only design identifies interactions of genetic risk variants at SIGLEC5 and PLG with the lncRNA CTD-2353F22.1 implying the importance of periodontal wound healing for disease aetiology."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Periodontol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcpe.13712"}], "href": "https://doi.org/10.1111/jcpe.13712"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36129033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36129033"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Elena Díaz-García, Aldara García-Sánchez, Enrique Alfaro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2023.1277551"}], "href": "https://doi.org/10.3389/fimmu.2023.1277551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37854605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37854605"}]}]}]}
|
| Synonyms | OB-BP2, SIGLEC-5, CD170, OBBP2 |
| Proteins | SIGL5_HUMAN |
| NCBI Gene ID | 8778 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SIGLEC5 has 2,895 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 81 datasets.
Click the + buttons to view associations for SIGLEC5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SIGLEC5 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SIGLEC5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SIGLEC5 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SIGLEC5 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SIGLEC5 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SIGLEC5 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SIGLEC5 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SIGLEC5 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SIGLEC5 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SIGLEC5 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SIGLEC5 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SIGLEC5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SIGLEC5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SIGLEC5 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SIGLEC5 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SIGLEC5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SIGLEC5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SIGLEC5 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SIGLEC5 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with SIGLEC5 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SIGLEC5 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SIGLEC5 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SIGLEC5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SIGLEC5 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SIGLEC5 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SIGLEC5 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SIGLEC5 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SIGLEC5 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SIGLEC5 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SIGLEC5 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SIGLEC5 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SIGLEC5 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SIGLEC5 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SIGLEC5 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SIGLEC5 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SIGLEC5 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SIGLEC5 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SIGLEC5 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding SIGLEC5 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SIGLEC5 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SIGLEC5 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SIGLEC5 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SIGLEC5 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SIGLEC5 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SIGLEC5 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SIGLEC5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SIGLEC5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SIGLEC5 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SIGLEC5 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SIGLEC5 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SIGLEC5 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SIGLEC5 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SIGLEC5 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SIGLEC5 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SIGLEC5 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SIGLEC5 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SIGLEC5 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SIGLEC5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SIGLEC5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SIGLEC5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SIGLEC5 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SIGLEC5 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SIGLEC5 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SIGLEC5 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SIGLEC5 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SIGLEC5 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SIGLEC5 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SIGLEC5 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SIGLEC5 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SIGLEC5 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving SIGLEC5 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SIGLEC5 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SIGLEC5 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SIGLEC5 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SIGLEC5 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SIGLEC5 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SIGLEC5 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SIGLEC5 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SIGLEC5 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SIGLEC5 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SIGLEC5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |